Monkeypox outbreak in the Tel Aviv District, Israel, 2022

OBJECTIVES: From May-September 2022, 203 cases of monkeypox (MPX) were reported in the Tel Aviv (TA) District, Israel. We aim to report the first ongoing local transmission of MPX in Israel. METHODS: We analyzed the epidemiologic and clinical features of all cases of MPX notified to the TA District....

Descripción completa

Detalles Bibliográficos
Autores principales: Sheffer, Rivka, Savion, Michal, Nuss, Naama, Amitai, Ziva, Salama, Matanelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773787/
https://www.ncbi.nlm.nih.gov/pubmed/36566775
http://dx.doi.org/10.1016/j.ijid.2022.12.023
_version_ 1784855266015051776
author Sheffer, Rivka
Savion, Michal
Nuss, Naama
Amitai, Ziva
Salama, Matanelle
author_facet Sheffer, Rivka
Savion, Michal
Nuss, Naama
Amitai, Ziva
Salama, Matanelle
author_sort Sheffer, Rivka
collection PubMed
description OBJECTIVES: From May-September 2022, 203 cases of monkeypox (MPX) were reported in the Tel Aviv (TA) District, Israel. We aim to report the first ongoing local transmission of MPX in Israel. METHODS: We analyzed the epidemiologic and clinical features of all cases of MPX notified to the TA District. Each case was contacted to verify the source of infection and locate potential contacts. RESULTS: All cases were men; 195 (96%) were among men having sex with men, and 171 (84%) resided in the city of TA. Median age was 35 years. One case occurred in a healthcare worker. All cases had a self-limiting disease. CONCLUSION: A combined public health campaign with vaccination against MPX of high-risk individuals leads to a decrease in disease rates. Enhanced surveillance and prevention among susceptible populations are warranted.
format Online
Article
Text
id pubmed-9773787
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-97737872022-12-22 Monkeypox outbreak in the Tel Aviv District, Israel, 2022 Sheffer, Rivka Savion, Michal Nuss, Naama Amitai, Ziva Salama, Matanelle Int J Infect Dis Short Communication OBJECTIVES: From May-September 2022, 203 cases of monkeypox (MPX) were reported in the Tel Aviv (TA) District, Israel. We aim to report the first ongoing local transmission of MPX in Israel. METHODS: We analyzed the epidemiologic and clinical features of all cases of MPX notified to the TA District. Each case was contacted to verify the source of infection and locate potential contacts. RESULTS: All cases were men; 195 (96%) were among men having sex with men, and 171 (84%) resided in the city of TA. Median age was 35 years. One case occurred in a healthcare worker. All cases had a self-limiting disease. CONCLUSION: A combined public health campaign with vaccination against MPX of high-risk individuals leads to a decrease in disease rates. Enhanced surveillance and prevention among susceptible populations are warranted. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023-03 2022-12-22 /pmc/articles/PMC9773787/ /pubmed/36566775 http://dx.doi.org/10.1016/j.ijid.2022.12.023 Text en © 2022 The Author(s) Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Short Communication
Sheffer, Rivka
Savion, Michal
Nuss, Naama
Amitai, Ziva
Salama, Matanelle
Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title_full Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title_fullStr Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title_full_unstemmed Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title_short Monkeypox outbreak in the Tel Aviv District, Israel, 2022
title_sort monkeypox outbreak in the tel aviv district, israel, 2022
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773787/
https://www.ncbi.nlm.nih.gov/pubmed/36566775
http://dx.doi.org/10.1016/j.ijid.2022.12.023
work_keys_str_mv AT shefferrivka monkeypoxoutbreakinthetelavivdistrictisrael2022
AT savionmichal monkeypoxoutbreakinthetelavivdistrictisrael2022
AT nussnaama monkeypoxoutbreakinthetelavivdistrictisrael2022
AT amitaiziva monkeypoxoutbreakinthetelavivdistrictisrael2022
AT salamamatanelle monkeypoxoutbreakinthetelavivdistrictisrael2022

Ejemplares similares